1887

Abstract

Group B coxsackieviruses (CVB) cause numerous diseases, including myocarditis, pancreatitis, aseptic meningitis and possibly type 1 diabetes. To date, infectious cDNA copies of CVB type 3 (CVB3) genomes have all been derived from pathogenic virus strains. An infectious cDNA copy of the well-characterized, non-pathogenic CVB3 strain GA genome was cloned in order to facilitate mapping of the CVB genes that influence expression of a virulence phenotype. Comparison of the sequence of the parental CVB3/GA population, derived by direct RT-PCR-mediated sequence analysis, to that of the infectious CVB3/GA progeny genome demonstrated that an authentic copy was cloned; numerous differences were observed in coding and non-coding sequences relative to other CVB3 strains. Progeny CVB3/GA replicated similarly to the parental strain in three different cell cultures and was avirulent when inoculated into mice, causing neither pancreatitis nor myocarditis. Inoculation of mice with CVB3/GA protected mice completely against myocarditis and pancreatitis induced by cardiovirulent CVB3 challenge. The secondary structure predicted for the CVB3/GA domain II, a region within the 5′ non-translated region that is implicated as a key site affecting the expression of a cardiovirulent phenotype, differs from those predicted for cardiovirulent and pancreovirulent CVB3 strains. This is the first report characterizing a cloned CVB3 genome from an avirulent strain.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80424-0
2005-01-01
2021-03-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/1/vir860197.html?itemId=/content/journal/jgv/10.1099/vir.0.80424-0&mimeType=html&fmt=ahah

References

  1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. 1990; Basic local alignment search tool. J Mol Biol 215:403–410 [CrossRef]
    [Google Scholar]
  2. Arnesjo B., Eden T., Ihse I., Nordenfelt E., Ursing B. 1976; Enterovirus infections in acute pancreatitis – a possible etiological connection. Scand J Gastroenterol 11:645–649
    [Google Scholar]
  3. Auvinen P., Mäkelä M. J., Roivainen M., Kallajoki M., Vainionpää R., Hyypiä T. 1993; Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides. APMIS 101:517–528 [CrossRef]
    [Google Scholar]
  4. Blyn L. B., Towner J. S., Semler B. L., Ehrenfeld E. 1997; Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol 71:6243–6246
    [Google Scholar]
  5. Bowles N. E., Richardson P. J., Olsen E. G., Archard L. C. 1986; Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet i:1120–1123
    [Google Scholar]
  6. Bradrick S. S., Lieben E. A., Carden B. M., Romero J. R. 2001; A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell-type-specific block to viral replication. J Virol 75:6472–6481 [CrossRef]
    [Google Scholar]
  7. Brown F., Talbot P., Burrows R. 1973; Antigenic differences between isolates of swine vesicular disease virus and their relationship to coxsackie B5 virus. Nature 245:315–316 [CrossRef]
    [Google Scholar]
  8. Chapman N. M., Tu Z., Tracy S., Gauntt C. J. 1994; An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol 135:115–130 [CrossRef]
    [Google Scholar]
  9. Chapman N. M., Kim K.-S., Tracy S., Jackson J., Höfling K., Leser J. S., Malone J., Kolbeck P. 2000a; Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice. J Virol 74:7952–7962 [CrossRef]
    [Google Scholar]
  10. Chapman N. M., Ragland A., Leser J. S., Höfling K., Willian S., Semler B. L., Tracy S. 2000b; A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice. J Virol 74:4047–4056 [CrossRef]
    [Google Scholar]
  11. Coller B.-A. G., Chapman N. M., Beck M. A., Pallansch M. A., Gauntt C. J., Tracy S. M. 1990; Echovirus 22 is an atypical enterovirus. J Virol 64:2692–2701
    [Google Scholar]
  12. Cornell C. T., Perera R., Brunner J. E., Semler B. L. 2004; Strand-specific RNA synthesis determinants in the RNA-dependent RNA polymerase of poliovirus. J Virol 78:4397–4407 [CrossRef]
    [Google Scholar]
  13. Dalldorf G. 1955; The coxsackie viruses. Annu Rev Microbiol 9:277–296 [CrossRef]
    [Google Scholar]
  14. De Jager H., Van Creveld S. 1956; Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data. Ann Pediatr 187:100–118
    [Google Scholar]
  15. de Jong A. S., Melchers W. J. G., Glaudemans D. H. R. F., Willems P. H. G. M., van Kuppeveld F. J. M. 2004; Mutational analysis of different regions in the coxsackievirus 2B protein: requirements for homo-multimerization, membrane permeabilization, subcellular localization, and virus replication. J Biol Chem 279:19924–19935 [CrossRef]
    [Google Scholar]
  16. de Verdugo U. R., Selinka H-C., Huber M., Kramer B., Kellermann J., Hofschneider P. H., Kandolf R. 1995; Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol 69:6751–6757
    [Google Scholar]
  17. Disney M. E., Howard E. M., Wood B. S. B., Findlay G. M. 1953; Bornholm disease in children. Br Med J 1:1351–1354 [CrossRef]
    [Google Scholar]
  18. Drescher K. M., Kono K., Bopegamage S., Carson S. D., Tracy S. 2004; Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329:381–394 [CrossRef]
    [Google Scholar]
  19. Dunn J. J., Chapman N. M., Tracy S., Romero J. R. 2000; Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J Virol 74:4787–4794 [CrossRef]
    [Google Scholar]
  20. Dunn J. J., Bradrick S. S., Chapman N. M., Tracy S. M., Romero J. R. 2003; The stem loop II within the 5′ nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. J Infect Dis 187:1552–1561 [CrossRef]
    [Google Scholar]
  21. Evans D., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. Jr 1985; Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314:548–550 [CrossRef]
    [Google Scholar]
  22. Gamarnik A. V., Andino R. 2000; Interactions of viral protein 3CD and poly(rC) binding protein with the 5′ untranslated region of the poliovirus genome. J Virol 74:2219–2226 [CrossRef]
    [Google Scholar]
  23. Gauntt C. J., Paque R. E., Trousdale M. D., Gudvangen R. J., Barr D. T., Lipotich G. J., Nealon T. J., Duffey P. S. 1983; Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect Immun 39:851–864
    [Google Scholar]
  24. Gomez R. M., Lascano E. F., Berria M. I. 1991; Murine acinar pancreatitis preceding necrotizing myocarditis after coxsackievirus B3 inoculation. J Med Virol 35:71–75 [CrossRef]
    [Google Scholar]
  25. Goodfellow I., Chaudhry Y., Richardson A., Meredith J., Almond J. W., Barclay W., Evans D. J. 2000; Identification of a cis -acting replication element within the poliovirus coding region. J Virol 74:4590–4600 [CrossRef]
    [Google Scholar]
  26. Goodfellow I. G., Kerrigan D., Evans D. J. 2003; Structure and function analysis of the poliovirus cis -acting replication element (CRE. RNA 9:124–137 [CrossRef]
    [Google Scholar]
  27. Haarmann C. M., Schwimmbeck P. L., Mertens T., Schultheiss H.-P., Strauer B. E. 1994; Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology 200:381–389 [CrossRef]
    [Google Scholar]
  28. Halim S., Ramsingh A. I. 2000; A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 269:86–94 [CrossRef]
    [Google Scholar]
  29. Hansen J. L., Long A. M., Schultz S. C. 1997; Structure of the RNA-dependent RNA polymerase of poliovirus. Structure 5:1109–1122 [CrossRef]
    [Google Scholar]
  30. He Y., Chipman P. R., Howitt J. 7 other authors 2001; Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 8:874–878 [CrossRef]
    [Google Scholar]
  31. Henke A., Zell R., Ehrlich G., Stelzner A. 2001; Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J Virol 75:8187–8194 [CrossRef]
    [Google Scholar]
  32. Höfling K., Tracy S., Chapman N., Kim K.-S., Leser J. S. 2000; Expression of an antigenic adenovirus epitope in a group B coxsackievirus. J Virol 74:4570–4578 [CrossRef]
    [Google Scholar]
  33. Huber S. A. 1997; Autoimmunity in myocarditis: relevance of animal models. Clin Immunol Immunopathol 83:93–102 [CrossRef]
    [Google Scholar]
  34. Huber S., Polgar J., Moraska A., Cunningham M., Schwimmbeck P., Schultheiss P. 1993; T lymphocyte responses in CVB3-induced murine myocarditis. Scand J Infect Dis Suppl 88:67–78
    [Google Scholar]
  35. Hyoty H., Hiltunen M., Lonnrot M. 1998; Enterovirus infections and insulin dependent diabetes mellitus – evidence for causality. Clin Diagn Virol 9:77–84 [CrossRef]
    [Google Scholar]
  36. Iizuka N., Yonekawa H., Nomoto A. 1991; Nucleotide sequences important for translation initiation of enterovirus RNA. J Virol 65:4867–4873
    [Google Scholar]
  37. Imrie C. W., Ferguson J. C., Sommerville R. G. 1977; Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut 18:53–56 [CrossRef]
    [Google Scholar]
  38. Jackson R. J., Kaminski A. 1995; Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1:985–1000
    [Google Scholar]
  39. Kandolf R., Hofschneider P. H. 1985; Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A 82:4818–4822 [CrossRef]
    [Google Scholar]
  40. Kanno T., Mackay D., Inoue T. 7 other authors 1999; Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus. J Virol 73:2710–2716
    [Google Scholar]
  41. Kanno T., Mackay D., Wilsden G., Kitching P. 2001; Virulence of swine vesicular disease virus is determined at two amino acids in capsid protein VP1 and 2A protease. Virus Res 80:101–107 [CrossRef]
    [Google Scholar]
  42. Kaplan M. H., Klein S. W., McPhee J., Harper R. G. 1983; Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. Rev Infect Dis 5:1019–1032 [CrossRef]
    [Google Scholar]
  43. Kawamura N., Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. 1989; Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol 63:1302–1309
    [Google Scholar]
  44. Kennedy J. D., Talbot I. C., Tanner M. S. 1986; Severe pancreatitis and fatty liver progressing to cirrhosis associated with coxsackie B4 infection in a three year old with alpha-1-antitrypsin deficiency. Acta Paediatr Scand 75:336–339 [CrossRef]
    [Google Scholar]
  45. Kibrick S., Benirschke K. 1958; Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with coxsackie virus, group B; evidence of intrauterine infection with this agent. Pediatrics 22:857–875
    [Google Scholar]
  46. Knowles N. J., McCauley J. W. 1997; Coxsackievirus B5 and the relationship to swine vesicular disease virus. Curr Top Microbiol Immunol 223:153–167
    [Google Scholar]
  47. Knowlton K. U., Jeon E.-S., Berkley N., Wessely R., Huber S. 1996; A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811–7818
    [Google Scholar]
  48. Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. 1988; A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol 62:2828–2835
    [Google Scholar]
  49. Le S.-Y., Chen J.-H., Sonenberg N., Maizel J. V. 1992; Conserved tertiary structure elements in the 5′ untranslated region of human enteroviruses and rhinoviruses. Virology 191:858–866 [CrossRef]
    [Google Scholar]
  50. Lee C., Maull E., Chapman N., Tracy S., Wood J., Gauntt C. 1997; Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs. Virus Res 50:225–235 [CrossRef]
    [Google Scholar]
  51. Li X., Lu H.-H., Mueller S., Wimmer E. 2001; The C-terminal residues of poliovirus proteinase 2Apro are critical for viral RNA replication but not for cis - or trans -proteolytic cleavage. J Gen Virol 82:397–408
    [Google Scholar]
  52. Liu Z., Carthy C. M., Cheung P., Bohunek L., Wilson J. E., McManus B. M., Yang D. 1999; Structural and functional analysis of the 5′ untranslated region of coxsackievirus B3 RNA: in vivo translational and infectivity studies of full-length mutants. Virology 265:206–217 [CrossRef]
    [Google Scholar]
  53. Longson M., Cole F. M., Davies D. 1969; Isolation of a coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult. J Clin Pathol 22:654–658 [CrossRef]
    [Google Scholar]
  54. Macadam A. J., Ferguson G., Burlison J., Stone D., Skuce R., Almond J. W., Minor P. D. 1992; Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. Virology 189:415–422 [CrossRef]
    [Google Scholar]
  55. Macadam A. J., Pollard S. R., Ferguson G., Skuce R., Wood D., Almond J. W., Minor P. D. 1993; Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192:18–26 [CrossRef]
    [Google Scholar]
  56. Martino T. A., Liu P., Petric M., Sole M. J. 1995; Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies. In Human Enterovirus Infections Edited by Rotbart H. A. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  57. Melnick J. L. 1996; Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Fields Virology , 3rd edn. pp  655–712 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott-Raven;
    [Google Scholar]
  58. Melnick J. L., Shaw E. W., Curnen E. C. 1949; A virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med 71:344–349 [CrossRef]
    [Google Scholar]
  59. Merkle I., van Ooij M. J. M., van Kuppeveld F. J. M., Glaudemans D. H. R. F., Galama J. M. D., Henke A., Zell R., Melchers W. J. G. 2002; Biological significance of a human enterovirus B-specific RNA element in the 3′ nontranslated region. J Virol 76:9900–9909 [CrossRef]
    [Google Scholar]
  60. Mertens T., Gruneklee D., Eggers H. J. 1983; Neutralizing antibodies against coxsackie B viruses in patients with recent onset of type I diabetes. Eur J Pediatr 140:293–294 [CrossRef]
    [Google Scholar]
  61. Minor P. D. 1992; The molecular biology of poliovaccines. J Gen Virol 73:3065–3077 [CrossRef]
    [Google Scholar]
  62. Minor P. D. 2003; Polio vaccines and the cessation of vaccination. Expert Rev Vaccines 2:99–104 [CrossRef]
    [Google Scholar]
  63. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986; Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67:1283–1291 [CrossRef]
    [Google Scholar]
  64. Muckelbauer J. K., Kremer M., Minor I., Diana G., Dutko F. J., Groarke J., Pevear D. C., Rossmann M. G. 1995; The structure of coxsackievirus B3 at 3·5 Å resolution. Structure 3:653–667 [CrossRef]
    [Google Scholar]
  65. Nathanson N., Martin J. R. 1979; The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol 110:672–692
    [Google Scholar]
  66. Nathanson N., McGann K., Wilesmith J., Desrosiers R., Brookmeyer R. 1993; The evolution of virus diseases: their emergence, epidemicity, and control. Virus Res 29:3–20 [CrossRef]
    [Google Scholar]
  67. Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. 1988; Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol 62:1781–1794
    [Google Scholar]
  68. Pallansch M. A., Roos R. P. 2001; Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Fields Virology , 4th edn. pp  723–775 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
    [Google Scholar]
  69. Racaniello V. R. 1988; Poliovirus neurovirulence. Adv Virus Res 34:217–246
    [Google Scholar]
  70. Racaniello V. R., Ren R. 1996; Poliovirus biology and pathogenesis. Curr Top Microbiol Immunol 206:305–325
    [Google Scholar]
  71. Ramsingh A. I. 1997; Coxsackieviruses and pancreatitis. Front Biosci 2:e53–e62
    [Google Scholar]
  72. Ramsingh A. I., Collins D. N. 1995; A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J Virol 69:7278–7281
    [Google Scholar]
  73. Ramsingh A., Hixson A., Duceman B., Slack J. 1990; Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome. J Virol 64:3078–3081
    [Google Scholar]
  74. Romero J. R., Price C., Dunn J. J. 1997; Genetic divergence among the group B coxsackieviruses. Curr Top Microbiol Immunol 223:97–152
    [Google Scholar]
  75. Sabin A. B. 1955; Characteristics and genetic potentialities of experimentally produced and naturally occurring variants of poliomyelitis virus. Ann N Y Acad Sci 61:924–938 [CrossRef]
    [Google Scholar]
  76. Sabin A. B., Boulger L. R. 1973; History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1:115–118 [CrossRef]
    [Google Scholar]
  77. Sherry B., Rueckert R. 1985; Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 53:137–143
    [Google Scholar]
  78. Sherry B., Mosser A. G., Colonno R. J., Rueckert R. R. 1986; Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 57:246–257
    [Google Scholar]
  79. Sigurdsson E., Bækkeskov S. 1990; The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol 164:143–168
    [Google Scholar]
  80. Smith C. P., Clements G. B., Riding M. H., Collins P., Bottazzo G. F., Taylor K. W. 1998; Simultaneous onset of type 1 diabetes mellitus in identical infant twins with enterovirus infection. Diabet Med 15:515–517 [CrossRef]
    [Google Scholar]
  81. Strauss D. M., Glustrom L. W., Wuttke D. S. 2003; Towards an understanding of the poliovirus replication complex: the solution structure of the soluble domain of the poliovirus 3A protein. J Mol Biol 330:225–234 [CrossRef]
    [Google Scholar]
  82. Tam P. E., Weber-Sanders M. L., Messner R. P. 2003; Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy. J Virol 77:11849–11854 [CrossRef]
    [Google Scholar]
  83. Towner J. S., Ho T. V., Semler B. L. 1996; Determinants of membrane association for poliovirus protein 3AB. J Biol Chem 271:26810–26818 [CrossRef]
    [Google Scholar]
  84. Tracy S., Chapman N. M., Tu Z. 1992; Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch Virol 122:399–409 [CrossRef]
    [Google Scholar]
  85. Tracy S., Höfling K., Pirruccello S., Lane P. H., Reyna S. M., Gauntt C. J. 2000; Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J Med Virol 62:70–81 [CrossRef]
    [Google Scholar]
  86. Tracy S., Drescher K. M., Chapman N. M., Kim K.-S., Carson S. D., Pirruccello S., Lane P. H., Romero J. R., Leser J. S. 2002; Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76:12097–12111 [CrossRef]
    [Google Scholar]
  87. Tu Z., Chapman N. M., Hufnagel G., Tracy S., Romero J. R., Barry W. H., Zhao L., Currey K., Shapiro B. 1995; The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J Virol 69:4607–4618
    [Google Scholar]
  88. Ursing B. 1973; Acute pancreatitis in coxsackie B infection. Br Med J 3:524–525 [CrossRef]
    [Google Scholar]
  89. Willian S., Tracy S., Chapman N., Leser J. S., Romero J. R., Shapiro B., Currey K. 2000; Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis. Arch Virol 145:2061–2086 [CrossRef]
    [Google Scholar]
  90. Yang D., Cheung P., Sun Y. 7 other authors 2003; A Shine-Dalgarno-like sequence mediates in vitro ribosomal internal entry and subsequent scanning for translation initiation of coxsackievirus B3 RNA. Virology 305:31–43 [CrossRef]
    [Google Scholar]
  91. Zell R., Sidigi K., Henke A., Schmidt-Brauns J., Hoey E., Martin S., Stelzner A. 1999; Functional features of the bovine enterovirus 5′-non-translated region. J Gen Virol 80:2299–2309
    [Google Scholar]
  92. Zhang G., Wilsden G., Knowles N. J., McCauley J. W. 1993; Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. J Gen Virol 74:845–853 [CrossRef]
    [Google Scholar]
  93. Zuker M. 2003; Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80424-0
Loading
/content/journal/jgv/10.1099/vir.0.80424-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error